8-K/A

NABI BIOPHARMACEUTICALS

Company: Vaxart, Inc.
Filed: October 7, 2003
Period of Report: August 4, 2003
Accession Number: 0000950144-03-011325

View Document ↗ View on SEC.gov ↗